HL7 Antitrust Policy

Professional Associations, such as HL7, which bring together competing entities are subject to strict scrutiny under applicable antitrust laws. HL7 recognizes that the antitrust laws were enacted to promote fairness in competition and, as such, supports laws against monopoly and restraints of trade and their enforcement. Each individual participating in HL7 meetings and conferences, regardless of venue, is responsible for knowing the contents of and adhering to the HL7 Antitrust Policy as stated in §05.01 of the Governance and Operations Manual (GOM).

Attendees

Please include your organization in your Zoom name.

• Click on your picture/name in Zoom
• Click on rename
• enter <name> - <organization>

Agenda Items and Notes

Outstanding Action Item List

Meeting Notes from previous meeting

• 2023-02-06 Meeting Notes  - accepted by general consent 

Project Proposals

Project Proposals in Review - none to review

Project Scope Statements

Project Scope Statements

PSS-2136 - Getting issue details... STATUS

• currently, there are no co-sponsors.  leveraging MedMorph.  No apparent need for pharmacy to be involved

External Meeting Review

Catalog Updates (John Hatem)

• 13 Feb 2023 - no meeting last week

Workflow Update (John Hatem)

• 13 Feb 2023  - no meeting this week

Healthcare Product Update (John Hatem)

• 13 Feb 2023 - discussed trackers. no pharmacy specific impact

EHR conformant reconciled medication list (cRML) (Scott Robertson / John Hatem / Jimmy Tcheng)

• 13 Feb 2023 - next meeting is beginning of March.  It is posted in the HL7 calendar. 
  • John and Scott attended. 
  • Jimmy will reach out to John on a "project scope" update.  The scope of the original PSS was very generic, too much so.  

Project updates

Pharmacy Templates

• 13 Feb 2023  - publication request in development

Trackers - Pharmacy Tracker Dashboard (see trackers for details / resolutions)

• Scott M. Robertson will review to make sure the 2 assigned to him are ready to discuss/vote next week

Status state diagram review 

• John reviewed the mapping between Med dispense status and BDP dispense status.  Suggestion was to send this to the list serve for input. 
  • 13 Feb 2023 review of mapping document.  
    
    • "ready for pickup" (in pharmacy) compares to "allocated" in BDP.
      • BDP "allocated" description is "ready for transport"   
    • "returned" - we don't have it, do we need it (returned after picked up).  usually these are wasted ... but can be reused in some cases. 
      • as opposed to "return to stock," which was "ready for pickup" and not received by patient.
    • pharmacy "completed" - BDP says "issued"
    • pharmacy "stopped" ("failed") - BDP uses "unfulfilled".
    • pharmacy "declined" ("not-done) - maybe BDP "returned" ("abandoned")

Timing questions (Jose)

13 Feb 2023 examples/questions from Dutch implementations

• physicians do order "between meals"
• alternating dosing - we do support
• duration without start date - we do support

• John Hatem will create Jira ticket for these changes - done FHIR-40440

NCPDP Updates (NCPDP Members)

no general updates

Pharmacist Consult Note (Scott)

• 13 Feb 2023 - received NCPDP Standardization Cochair approval, with a number of editorial (formatting) corrections.  

Specialty Medication Enrolment IG

• 13 Feb 2023  - all resolutions have been applied.  One mechanical issue with linkage to FHIR tooling.  Publication request should be available for next call.

Any Other Business

Next meeting:

• 20 Feb 2023